4//SEC Filing
Lawton Alison Frances 4
Accession 0000950170-24-065540
CIK 0001690585other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 7:58 PM ET
Size
5.6 KB
Accession
0000950170-24-065540
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-23+11,000→ 11,000 totalExercise: $21.77Exp: 2034-05-22→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 7:58 PM ET
- Size
- 5.6 KB